US spice maker McCormick & Co. has won the battle to buy Reckitt Benckiser’s North American food business, paying a higher than expected $4.2 billion to add extra seasonings and sauces. London-listed Reckitt said in April it was reviewing options for the unit, which includes French’s mustard and Frank’s RedHot sauce, to cut its debt...
NYS Entity Status
NYS Filing Date
DECEMBER 05, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2013 - FRENCH IN US, LLC
AROUND THE WEB
- Spice giant McCormick buys owner of French’s mustard
By Reuters - Wednesday Jul 19, 2017
- Fit City: Taking Night-Life Cue, Gyms Lower the Lights
By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017
Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.
- Trump touts US-French relationship amid Bastille Day celebrations
By Reuters - Friday Jul 14, 2017
PARIS – President Donald Trump watched U.S. and French soldiers march together through the Paris sunshine on Friday in a double celebration marking 100 years since the United States entered World War One and France’s annual Bastille Day holiday. The occasion, also featuring a bi-national fly-past of fighter jets symbolizing military cooperation in the Middle...
- North Korea Accuses U.S. of ‘Mugging’ Its Diplomats in New York
By CHOE SANG-HUN - Sunday Jun 18, 2017
Officials returning from a United Nations conference were about to board a plane when federal agents seized a package they were carrying.
- US soldier charged with killing 2 plotted 1999 school attack
Tuesday Jul 11, 2017
THERESA, N.Y. (AP) — Court records show that a U.S. Army soldier charged with killing his wife and a New York State Police trooper once plotted to shoot up his Michigan middle school while a teenager.
- “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
By Ben Fidler - Wednesday Jun 7, 2017
Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]